Skip to main content

Table 3 Trends for age and race derived from each time period for different hormone receptor statuses of metaplastic breast cancer. Analysis adjusted for age, race, marital status, median household income, pathologic grade, T stage, and lymph node status

From: Survival trends of patients with metaplastic breast carcinoma with different hormone receptor statuses: a SEER-based retrospective cohort study

 

Hormone Receptor-Negative

Hormone Receptor-Positive

 
 

2000–2009

2010–2019

 

2000–2009

2010–2019

  

Variable

%

OR

%

OR (95% CI)

P

%

OR

%

OR (95% CI)

P

 

Age

           

≥ 50

75.4

1

79.3

1.25(1.01–1.53)

0.037

74.8

1

73.4

1.06(0.71–1.57)

0.759

 

Race/Ethnicity

           

Black

13.1

1

15.6

1.18(0.92–1.51)

0.205

16.7

1

15.8

1.05(0.67–1.67)

0.841

 

White

68.5

1

64.2

0.78(0.65–0.94)

0.009

67.6

1

59.3

0.72(0.51–1.02)

0.066

 

Hispanic

12.3

1

12.6

1.13(0.87–1.48)

0.359

8.1

1

12.6

1.40(0.80–2.56)

0.251

 

Other

6.1

1

7.5

1.37(0.97–1.94)

0.076

7.6

1

12.3

1.60(0.91–2.97)

0.116

 

Node Statusa

           

Positive

22.9

1

17.9

0.72(0.58–0.90)

0.003

27.1

1

22.5

0.69(0.47–1.01)

0.056

 

Negative

70.4

1

75.3

1.33(1.10–1.62)

0.004

64.3

1

68.9

1.31(0.92–1.85)

0.128

 

T Stage

           

T0&T1

23.0

1

25.8

1.16(0.94–1.42)

0.167

33.8

1

26.2

0.63(0.44–0.92)

0.015

 

T2

54.4

1

49.2

0.81(0.68–0.96)

0.016

44.3

1

51.6

1.35(0.98–1.87)

0.069

 

T3

15.9

1

17.3

1.11(0.88–1.40)

0.379

14.3

1

15.0

1.10(0.70–1.78)

0.686

 

T4

6.7

1

7.7

1.22(0.87–1.72)

0.258

7.6

1

7.1

1.08(0.58–2.10)

0.810

 
  1. Abbreviations: OR odds ratio, CI confidence interval
  2. aAnalysis not shown for an unknown race. bAnalysis not shown for unknown node status